917023-46-2

Upstream product

• 917200-88-5 [4'-(1-ethyl-1-{4-[(E)-2-(1-hydroxy-cyclopentyl)-vinyl]-3-methyl-phenyl}-propyl)-3-fluoro-2'-methyl-biphenyl-4-yl]-acetic acid 
• 55041-27-5 3,3-bis[4-hydroxy-3-methylphenyl]pentane 
• 17356-19-3 1-ethynylcyclopentanol 
• 917022-96-9 1-[(E)-2-(4-{1-ethyl-1-[3-methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propyl}-2-methyl-phenyl)-vinyl]-cyclopentanol 
• 917024-89-6 trifluoromethanesulfonic acid 4-(1-ethyl-1-{4-[(E)-2-(1-hydroxy-cyclopentyl)-vinyl]-3-methyl-phenyl}-propyl)-2-methyl-phenyl ester 
• 917023-04-2 methyl 2-(4-chloro-2-fluorophenyl)acetate 
• 194240-75-0 2-(4-chloro-2-fluorophenyl)acetic acid 
• 865235-89-8 trifluoromethanesulfonic acid 4-[1-ethyl-1-(4-hydroxy-3-methylphenyl)-propyl]-2-methylphenyl ester 
• 865236-04-0 4-(1-ethyl-1-[4-(1-hydroxycyclopentylethynyl)-3-methylphenyl]propyl)-2-methylphenol 
• 865236-07-3 4-(1-ethyl-1-(4-[(E)-2-(1-hydroxycyclopentyl)-vinyl]-3-methylphenyl)propyl)-2-methylphenol 
• 917025-54-8 [4'-(1-ethyl-1-{4-[(E)-2-(1-hydroxy-cyclopentyl)-vinyl]-3-methyl-phenyl}-propyl)-3-fluoro-2'-methyl-biphenyl-4-yl]-acetic acid methyl ester 

Relevant academic research and scientific papers

VITAMIN D-LIKE COMPOUND

The present invention provides a compound represented by the following general formula (I): or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound, and the like. The compound or a pharmaceutically acceptable